Lead party: SPE Capital Partners (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Amanys Pharma (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Morocco
Transaction type: Investment · Asset class: Private Equity · Strategy: Buyout · Instrument: Equity · Equity stake: 1% · Fund: SPE Africa Industrialisation Fund I
Investors/buyers: SPE Capital Partners, Proparco
Legal advisers: not identified in the source record.
Source: announced 1 April 2020. Original announcement: spe-capital.com.


